Prometheus Homeopathic Institute, LLC – Trademark Portfolio
Entity Type: 16
Prometheus Homeopathic Institute, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include THE FIRST REMEDY IS LOVE. The owner is based in Stillwater, MN.
141 Deer Path
Stillwater, MN 55082
Showing of trademarks Trademarks
Trademark Classifications
Prometheus Homeopathic Institute, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Prometheus Homeopathic Institute, LLC have?
Prometheus Homeopathic Institute, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Prometheus Homeopathic Institute, LLC file in?
Prometheus Homeopathic Institute, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Prometheus Homeopathic Institute, LLC's most well-known trademarks?
Prometheus Homeopathic Institute, LLC's registered trademark portfolio includes well-known marks such as THE FIRST REMEDY IS LOVE. These are among 1 currently registered trademark in the portfolio.
What is Prometheus Homeopathic Institute, LLC's trademark registration success rate?
Prometheus Homeopathic Institute, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.